%0 Journal Article %A Albert Lee %A Yaye Die Ndiaye %A Aida Badiane %A Awa Deme %A Rachel F. Daniels %A Stephen F. Schaffner %A Fatou Ba Fall %A Médoune Ndiop %A Alioune Badara Gueye %A Ibrahima Diallo %A Katherine E. Battle %A Edward A. Wenger %A Caitlin A. Bever %A Doudou Sene %A Bronwyn MacInnis %A Dyann F. Wirth %A Daouda Ndiaye %A Daniel L. Hartl %A Sarah K. Volkman %A Joshua L. Proctor %T Modeling the levels, trends, and connectivity of malaria transmission using genomic data from a health facility in Thiès, Senegal %D 2021 %R 10.1101/2021.09.17.21263639 %J medRxiv %P 2021.09.17.21263639 %X Molecular data and analysis outputs are being integrated into malaria surveillance efforts to provide valuable programmatic insights for national malaria control programs (NMCPs). A plethora of studies from diverse geographies have demonstrated that malaria parasite genetic data can be an important tool for drug resistance monitoring, species identification, outbreak analysis, and transmission characterization. Despite many successful research efforts, there are still important knowledge gaps hindering practical translation of each of these use cases for NMCPs. Here, we leverage epidemiological modeling and time-series data of 2035 genetic sequences collected in Thiès, Senegal from 2006-2018 to provide a quantitative and setting-specific assessment of the levels, trends, and connectivity of malaria transmission. We also identify the genetic features that are the most informative for inferring transmission in Thiès, such as the fraction of the population with multiple infections and the persistence of parasite lineages across multiple transmission seasons. The model fitting and uncertainty quantification framework also reveals a significant decrease in the level of malaria transmission around 2013. This difference coincides with a large-scale drought and bed net campaign by the NMCP and USAID and is independently corroborated by geo-spatial models of incidence in Thiès. We find that genetically identical samples are more likely to be geographically clustered even at the neighborhood scale; and moreover, these lineages propagate non-randomly around the city. Our approach and results provide quantitative guidance for the interpretation of malaria parasite genetic data from Thiès, Senegal and indicates the value of increased malaria genomic surveillance for NMCPs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis publication is based on research funded in part by the Bill & Melinda Gates Foundation (BMGF), including modeling and analysis performed by the Institute for Disease Modeling at BMGF. Funding for this work at the Harvard T.H. Chan School of Public Health and the Broad Institute was provided by a BMGF grant to D.F.W. (OPP1156051). We would like to thank the collection team at the SLAP clinic, including Younouss Diedhiou, the Field Lab Coordinator, Dr. Ngayo Sy, the Director, and all the nurses. We would also like to thank the residents of Thiès who have participated in these ongoing studies since 2006. We thank Amy K. Bei, Sidiya Mbodj, and Fatoumata Dabo for help collecting neighborhood GPS coordinates and harmonizing village names from Wolof for the spatial analysis used in the model.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol was approved by the ethical committees of the Senegal Ministry of Health and the Harvard T.H. Chan School of Public Health (Protocol Number 16330)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon acceptance to peer reviewed journal. %U https://www.medrxiv.org/content/medrxiv/early/2021/10/01/2021.09.17.21263639.full.pdf